Home Podcasts GTSC Podcast

GTSC Podcast

General Thoracic Surgical Club 7 Episodes Aug 5, 2026

The GTSC Podcast provides periodic updates from the General Thoracic Surgical Club, a professional organization for thoracic surgeons. Episodes likely cover developments in the field, research findings, clinical practice topics, and news relevant to thoracic surgery. The podcast serves as a resource for members and interested medical professionals.

Episodes

Borderline Resectable NSCLC in the Era of Perioperative Chemo-ICI Aug 5, 2026 39:07 In this GTSC podcast, Dr. Elliot Servais joins Dr. Jessica Donington and Dr. Biniam Kidane to explore the complex judgment involved in assessing resectability in the era of perioperative chemoimmunotherapy. The discussion highlights the critical distinctions among technical, oncologic, and physiologic resectability, as well as the essential role of surgeons and the multidisciplinary team in guidin

Lung nodule localization prior to thoracic surgery Oct 21, 2025 47:16 In this episode of the General Thoracic Surgical Podcast, Dr. Linda Martin and Dr. Rishi Reddy explore the rapidly evolving landscape of lung nodule localization—a critical topic as thoracic surgeons increasingly encounter smaller, non-palpable nodules due to expanded screening and imaging practices. The conversation covers the full spectrum of localization techniques—from traditional wire and dye

Changes in Early-Stage Lung Cancer Treatments Options Aug 18, 2025 51:11 In this podcast, Drs. Linda Martin (UVA) and Dennis Wigle (Mayo Clinic Rochester, MN) discuss key updates in the treatment of early stage surgically resectable non small cell lung cancer from the 2025 American Society of Clinical Oncology Annual Meeting. Topics include updated survival data from the CheckMate 816 trial of neoadjuvant nivolumab plus chemotherapy, the practice impact of PROSPECT lun

N2 Disease - Are There Any Rules Anymore! Sep 18, 2024 40:24 In this podcast, Drs. Linda Martin and Jessica Donington discuss the evolving approach to treating N2 disease in stage 3 lung cancer, emphasizing the shift from therapeutic nihilism to more aggressive surgical strategies. They highlight the success of combining chemotherapy, immunotherapy, and surgery, which has led to improved outcomes, especially in patients with multi-station N2 disease, while

ALINA Trial and Adjuvant Therapy Jun 18, 2024 50:56 In this episode of the GTSC podcast, Dr. Dennis Wigle (Mayo Clinic) and Dr. Linda Martin (UVA) review the recently published ALINA trial of adjuvant alectinib for resected ALK-positive NSCLC. We also review recently presented lung and esophageal cancer data from ASCO 2024, including ESOPEC, CheckMate 816 and 77T, AEGEAN, and the LU002 trial results for oligometastatic lung cancer. This podcast is

ESMO Meeting Update & Looking Ahead to 2024 Jan 8, 2024 42:44 Dennis Wigle and Linda Martin from Mayo Clinic and University of Virginia, respectively, discuss recent trials from the meeting of the European Society for Medical Oncology (ESMO), particularly highlighting the ALINA trial focusing on adjuvant treatments for resected non small cell lung cancers with impressive differences in outcomes between Alectinib and platinum-based chemotherapy. In addition,

What's new in Thoracic Surgery for lung cancer Oct 30, 2023 54:32 Drs. Linda Martin (University of Virginia) and Dennis Wigle (Mayo Clinic) review recent clinical trial publications on sublobar resection for early stage lung cancer, and the use of immunotherapy before surgery for later stage (locally advanced) lung cancer. We review the studies involved and provide perspective on the results and what they mean for patient care. This podcast is sponsored by Genen

GTSC Podcast

Episodes

Recommended